Evidence map›Paper›PMID 30455353›Full record

ArticleThe Journal of biological chemistry2019

Deficiency of cathepsin C ameliorates severity of acute pancreatitis by reduction of neutrophil elastase activation and cleavage of E-cadherin.

Daniel S John, Julia Aschenbach, Burkhard Krüger, Matthias Sendler, F Ulrich Weiss, Julia Mayerle, Markus M Lerch, Ali A Aghdassi

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Acute pancreatitis: mechanisms and therapeutic approaches.Signal transduction and targeted therapy · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Mobilization of CD11bFrontiers in immunology · 2022
    Article
  10. Circulating monocytes in acute pancreatitis.Frontiers in immunology · 2022
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Daniel S JohnFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
Julia AschenbachFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
Burkhard Krügerthe Division of Medical Biology, University of Rostock, 18051 Rostock, Germany, and.
Matthias SendlerFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
F Ulrich WeissFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
Julia MayerleFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.
Markus M LerchFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany.ORCID 0000-0002-9643-8263
Ali A AghdassiFrom the Department of Medicine A, University Medicine Greifswald, 17475 Greifswald, Germany, aghdassi@uni-greifswald.de.
Universitätsmedizin Greifswald · DEUniversity of Rostock · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute pancreatitis is characterized by premature intracellular protease activation and infiltration of inflammatory cells, mainly neutrophil granulocytes and macrophages, into the organ. The lysosomal proteases cathepsin B, D, and L have been identified as regulators of early zymogen activation and thus modulators of the severity of pancreatitis. Cathepsin C (CTSC, syn. dipeptidly-peptidase I) is a widely expressed, exo-cystein-protease involved in the proteolytic processing of various other lysosomal enzymes. We have studied its role in pancreatitis. We used CTSC-deleted mice and their WT littermates in two experimental models of pancreatitis. The mild model involved eight hourly caerulein injections and the severe model partial duct ligation. Isolated pancreatic acini and spleen-derived leukocytes were used for

Indexed as

Acinar CellsAcute DiseaseAnimalsCadherinsCathepsin CCells, CulturedEnzyme ActivationGene DeletionLeukocyte ElastaseMicePancreatitisCadherinsCathepsin CLeukocyte Elastaseacute pancreatitiscadherin-1 (CDH1) (epithelial cadherin) (E-cadherin)cathepsin C (CTSC)cell biologydipeptidyl-peptidase Ileukocytelysosomal proteaseneutrophilneutrophil elastasepancreas

Identifiers

PMID30455353
PMCPMC6333881
OpenAlexW2901901034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.